艾尔巴韦/格拉瑞韦治疗基因1b 型慢性丙型肝炎患者疗效研究

许海玲, 秦刚, 薛红, 章颖 - 实用肝脏病杂志, 2022 - manu43.magtech.com.cn
目的探讨应用艾尔巴韦/格拉瑞韦治疗基因1b 型慢性丙型肝炎(CHC) 患者的疗效. 方法2018 年6
月~ 2020 年12 月我院收治的68 例基因1b 型CHC 患者, 被随机分为观察组34 例和对照组34 …

[HTML][HTML] Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability …

E Warren, BJC Castles, GC Sharratt… - Infectious Diseases and …, 2024 - Springer
Introduction The first direct-acting antiviral (DAA) therapies for chronic hepatitis C virus
(HCV) infection were reimbursed via Australia's Pharmaceutical Benefits Scheme (PBS) in …

[HTML][HTML] National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents

MLG Ferraz, LZ Piccoli, R Rezende… - Brazilian Journal of …, 2022 - SciELO Brasil
Background and aims: Treatment of hepatitis C with direct antiviral agents (DAA) is
associated with almost 95% of sustained virological response. However, some patients …

Establishing a research production line in real-life settings: the case of Hepatitis C management in a viral hepatitis specialized Egyptian center

M El Kassas, M Eltabbakh, M Elbadry… - Current Medical …, 2022 - Taylor & Francis
Efforts toward eradicating the Hepatitis C virus (HCV) have advanced rapidly, due to the
development of direct-acting antivirals (DAAs), especially with the appearance of pan …

Liver diseases among Arab world, current state and unmet needs, a scoping review

Y Almansoury, M Abdel-Gawad… - Global …, 2023 - journals.ekb.eg
Liver diseases are increasing nowadays worldwide with increase in morbidity and mortality,
which cause a burden to countries. we aimed to provide an overview of the current state and …

[PDF][PDF] Liver diseases among Arab world, current state and unmet needs, a scoping

Y Almansoury₁, M Abdel-Gawad₂, M Abdelghani₃… - gg.journals.ekb.eg
A worrisome increase in liver diseases over the recent decades is noticed. Liver diseases
are major causes of death and disability in Arab world, present with different patterns in all …

[引用][C] Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of …

EWBJCC Gillian, C Sharratt - 2024